| Literature DB >> 32975692 |
Meng Lu1,2,3, Jindong Guo2,3, Bowen Wu2,4, Yuhui Zhou1,2,3, Mishan Wu5,6, Maryam Farzaneh7, Seyed Esmaeil Khoshnam8.
Abstract
Stroke is the leading cause of death and adult disability worldwide. Mitochondrial dysfunction is one of the hallmarks of stroke-induced neuronal death, and maintaining mitochondrial function is essential in cell survival and neurological progress following ischemic stroke. Stem cell-mediated mitochondrial transfer represents an emerging therapeutic approach for ischemic stroke. Accumulating evidence suggests that mesenchymal stem cells (MSCs) can directly transfer healthy mitochondria to damaged cells, and rescue mitochondrial damage-provoked tissue degeneration. This review summarizes the research on MSCs-mediated mitochondrial transfer as a therapeutic strategy against ischemic stroke.Entities:
Keywords: Ischemic stroke; Mesenchymal stem cells; Mitochondria
Mesh:
Year: 2020 PMID: 32975692 DOI: 10.1007/s12975-020-00853-6
Source DB: PubMed Journal: Transl Stroke Res ISSN: 1868-4483 Impact factor: 6.829